Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 9—September 2007

Dispatch

Rickettsia monacensis and Human Disease, Spain

Isabel Jado*, José A. Oteo†, Mikel Aldámiz‡, Horacio Gil*, Raquel Escudero*, Valvanera Ibarra†, Joseba Portu‡, Aranzazu Portillo†, María J. Lezaun‡, Cristina García-Amil*, Isabel Rodríguez-Moreno*, and Pedro Anda*Comments to Author 
Author affiliations: *Centro Nacional de Microbiología, Majadahonda, Madrid, Spain; †Complejo San Millán-San Pedro de La Rioja, Logroño, Spain; ‡Hospital de Txagorritxu, Vitoria, Spain;

Main Article

Table

Microimmunofluorescence titers obtained with different rickettsial antigens, 2 patients, northern Spain, 2003*

Patient Week† Rickettsia conorii R. monacensis R. helvetica R. akari R. australis
1 1 <1:40 <40 <40 <40 <40
4 1,280 2,560 2,560 1,280 640
13 1,280 1,280 1,280 1,280 1,280

26
1,280
1,280
1,280
320
320
2 1 640 2,560 2,560 640 320
4 320 1,280 1,280 320 160
6 640 1,280 1,280 320 160

*A 1-fold decrease in titer is considered not significant.
†Week after symptom onset in which the samples were extracted.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO